Zacks Initiates Coverage of NeurAxis With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of NeurAxis, Inc. NRXS, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook for the company,...
Stocks in play: NeurAxis, Inc.
Today highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field ...
This Could Help Treat Post-Concussion Syndrome in Children
Every year, an estimated 1.6 million to 3.8 million sports- and recreation-related concussions are seen, as noted by the Brain Injury Research Institute (BIRI), adding that, “During 2001-2005, children...